Literature DB >> 12428245

Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis.

Margherita Massa1, Nick Costouros, Federica Mazzoli, Fabrizio De Benedetti, Antonio La Cava, Tho Le, Isme De Kleer, Angelo Ravelli, Margaret Liotta, Sarah Roord, Charles Berry, Lauren M Pachman, Alberto Martini, Salvatore Albani.   

Abstract

OBJECTIVE: To identify self T cell epitopes associated with proinflammatory immune responses and clinically active juvenile dermatomyositis (juvenile DM). The target of our search for relevant epitopes was represented by amino acid sequences shared between human skeletal myosin and Streptococcus pyogenes M5 protein. The long-term objective of the project is to identify suitable targets for immunotherapy of the disease.
METHODS: We used computerized algorithms to identify putative agretopes on both the human myosin and Streptococcus M5 proteins. Direct binding assays for homolog peptides were used to confirm such predictions. Antigenicity and functional cross-reactivity were evaluated by cytotoxicity assays and by measurement of cytokine levels. Specific T cells were isolated by T cell capture, and T cell receptor (TCR) V(beta) gene usage was identified by reverse transcriptase-polymerase chain reaction.
RESULTS: We identified peptides that are targets of disease-specific cytotoxic T cell responses. T cell reactivity against the self peptides correlates with clinical signs of early, active myositis. Such reactivity is accompanied by production of proinflammatory cytokines, which may contribute to the damage. T cell cross-recognition of bacterial and human homologs was shown functionally as well as by sorting peptide-specific T cells and identifying oligoclonal and largely overlapping TCR V(beta) gene usage.
CONCLUSION: These findings represent the first identification of a self epitope in juvenile DM, providing a potential candidate for antigen-specific immune therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428245     DOI: 10.1002/art.10566

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

1.  An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.

Authors:  Emily C Baechler; Jason W Bauer; Catherine A Slattery; Ward A Ortmann; Karl J Espe; Jill Novitzke; Steven R Ytterberg; Peter K Gregersen; Timothy W Behrens; Ann M Reed
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

Review 2.  Juvenile dermatomyositis.

Authors:  Michelle Batthish; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

Review 3.  Microbiota—implications for immunity and transplantation.

Authors:  Jonathan S Bromberg; W Florian Fricke; C Colin Brinkman; Thomas Simon; Emmanuel F Mongodin
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 4.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

Review 5.  Intravenous immunoglobulin therapy in rheumatic diseases.

Authors:  Jagadeesh Bayry; Vir Singh Negi; Srini V Kaveri
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

6.  MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.

Authors:  Kevin A O'Connor; Kathy A Abbott; Brad Sabin; Maxine Kuroda; Lauren M Pachman
Journal:  Clin Immunol       Date:  2006-07-21       Impact factor: 3.969

7.  Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile dermatomyositis syndrome.

Authors:  K Mizuno; A Yachie; S Nagaoki; H Wada; K Okada; M Kawachi; T Toma; A Konno; K Ohta; Y Kasahara; S Koizumi
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 8.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

9.  Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.

Authors:  Timothy B Niewold; Silvia N Kariuki; Gabrielle A Morgan; Sheela Shrestha; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2009-06

10.  Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis.

Authors:  Berent J Prakken; Rodrigo Samodal; Tho D Le; Francesca Giannoni; Gisella Puga Yung; John Scavulli; Diane Amox; Sarah Roord; Isme de Kleer; Dustan Bonnin; Paola Lanza; Charles Berry; Margherita Massa; Rosario Billetta; Salvatore Albani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.